cas 55151-91-2|| where to buy 2-(3-Methyl-1,2,4-oxadiazol-5-yl)acetic acid

Nom du produit:2-(3-Methyl-1,2,4-oxadiazol-5-yl)acetic acid

IUPAC Name:2-(3-methyl-1,2,4-oxadiazol-5-yl)acetic acid

Unité d'emballage	Stock disponible	Prix($)
CM323289-100mg	in stock	șƞ
CM323289-250mg	in stock	ŭŭ
CM323289-1g	in stock	ȀȀș

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 55151-91-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:55151-91-2; Formule moléculaire:C5H6N2O3; Point de fusion:-; Code SMILES:O=C(O)CC1=NC(C)=NO1; Densité:

: Numéro de catalogue:CM323289; Poids moléculaire:142.11; Point d'ébullition:; N° Mdl:MFCD13705349; Stockage:

: Oxadiazoles; Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.

: Navacaprant; Navacaprant, a novel and selective kappa opioid receptor(KOR) antagonist, has no agonist properties implicated in opioid-related abuse.
Navacaprant is a potent KOR antagonist currently in clinical development for the treatment of neurobehavioral disorders, including Phase 3 clinical trials in adults with major depressive disorder. Navacaprant demonstrates high affinity and selectivity for the human KOR over the human MOR and DOR and exhibits reversible antagonist activity at KOR ex vivo and in vivo.